Biotechnology news · Pharma Industry News. Watson Pharmaceuticals, Inc
Biotechnology news · Pharma Industry News. Sinapis Pharma, Inc.
Clal Biotechnology Industries’ share price gained 8% yesterday after its portfolio company MediWound announced successful Phase III clinical trial results for its flagship product Debrase gel dressing, which is used to treat second- and …
Generex Biotechnology Corp. (NasdaqCM: GNBT) announced a publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer
Auto industry job offers that appeal to a wide range of interests and development options for a rich and those who have the proper training. The current range of cars and car service post of Director of mechanics and functions.
Generex Biotechnology Corporation announced today publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer. At the end of 2009, the Company announced positive interim results from a Phase II trial being conducted with AE37 in patients with breast cancer. The compound is being developed by its wholly-owned subsidiary, Antigen …
Generex Biotechnology Corporation announced today publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer. At the end of 2009, the Company announced positive interim results from a Phase II trial being conducted with AE37 in patients with breast cancer
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.